Thursday, March 19, 2026

From R&D to Global Blockbuster: Fexuclue Sparks a New Vision for Daewoong

Daewoong Pharmaceutical's Fexuclue achieves rapid success with innovative marketing and aims for significant growth in treating GERD.

Arm Shares Fall 3.21% After NVIDIA Halves Stake, Despite AI Chip News

Arm Holdings' stock fluctuated after NVIDIA cut its investment, despite plans to launch AI-specific chips later this year.

Micron’s Latest Forecast Shakes Up Future of U.S. Stock

One of the largest DRAM companies in...

Tag: chronic spontaneous urticaria

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Saving Poverty vs Free Trade Society? How Celltrion’s Biosimilar Could Reshape the U.S. Healthcare Market

Professor Metz highlights biosimilars' potential to expand patient access to treatments, emphasizing Omliclo's impact at EADV conference.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.